The global cancer biopsy market size was valued at USD 30.96 billion in 2024 and is estimated to reach from USD 33.38 billion ...
Core-needle biopsies can also be ultrasound-guided, or a doctor may use an MRI or mammogram machine. This latter procedure is called a stereotactic breast biopsy. The ACS notes if the results of a ...
If the evaluation is nondiagnostic, either aspiration should be reattempted or core-needle or excisional biopsy should be performed. If the FNA biopsy results are negative, core-needle or ...
Key updates from SABCS 2024 in early breast cancer include the COMET study on DCIS recurrence, INSEMA trial on SLNB omission, and OlympiA updates on adjuvant olaparib, shared by Dr Harold Burstein.